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Abstract
Mathematical modelling has proven an important tool in elucidating and quantifying mechanisms that govern the age
structure and population dynamics of red blood cells (RBCs). Here we synthesise ideas from previous experimental data and
the mathematical modelling literature with new data in order to test hypotheses and generate new predictions about these
mechanisms. The result is a set of competing hypotheses about three intrinsic mechanisms: the feedback from circulating
RBC concentration to production rate of immature RBCs (reticulocytes) in bone marrow, the release of reticulocytes from
bone marrow into the circulation, and their subsequent ageing and clearance. In addition we examine two mechanisms
specific to our experimental system: the effect of phenylhydrazine (PHZ) and blood sampling on RBC dynamics. We
performed a set of experiments to quantify the dynamics of reticulocyte proportion, RBC concentration, and erythropoietin
concentration in PHZ-induced anaemic mice. By quantifying experimental error we are able to fit and assess each
hypothesis against our data and recover parameter estimates using Markov chain Monte Carlo based Bayesian inference. We
find that, under normal conditions, about 3% of reticulocytes are released early from bone marrow and upon maturation all
cells are released immediately. In the circulation, RBCs undergo random clearance but have a maximum lifespan of about 50
days. Under anaemic conditions reticulocyte production rate is linearly correlated with the difference between normal and
anaemic RBC concentrations, and their release rate is exponentially correlated with the same. PHZ appears to age rather
than kill RBCs, and younger RBCs are affected more than older RBCs. Blood sampling caused short aperiodic spikes in the
proportion of reticulocytes which appear to have a different developmental pathway than normal reticulocytes. We also
provide evidence of large diurnal oscillations in serum erythropoietin levels during anaemia.
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Introduction
Mathematical modelling has proven an important tool in
elucidating and quantifying the mechanisms that govern physio-
logical processes. Here we are concerned with understanding the
processes responsible for the age structure and population
dynamics of red blood cells (RBC). There are two main fields of
research developing mathematical models of the dynamics of the
erythropoietic system. Interestingly, both fields appear to progress
in isolation from each other. The first, pioneered by Mackey [1],
has mainly focused on explaining periodic haematological diseases
by exploring how the feedback from the circulating RBC
population influences self-renewal, maturation and apoptosis of
RBC progenitors (erythroid progenitors) in bone marrow ([2–9],
see [10] for a detailed review of the literature). The approach is
fairly theoretical: modifications to previous models—in the light of
new evidence in the literature—are examined from a dynamical
systems point of view, often with an emphasis on integrating
partial differential equation models to time-delay ordinary
differential equation models. Model testing against real data is
rarely undertaken ([9] is one exception), and fits are qualitative.
The second field of research, pioneered by Veng-Pedersen and co-
workers [11], has focused on developing pharmaceutic PK/PD
models to explain perturbations to RBC, immature RBC
(reticulocyte), erythropoietin (Epo) and haemoglobin dynamics
induced by phlebotomy, recombinant human Epo or chemother-
apeutic drugs [12–18]. This approach is directed at explaining
reticulocyte dynamics as this is commonly used for clinical
diagnoses and management of anaemia (see [16] and references
therein). Model fitting to data and parameter estimation is integral
to this approach.
One of our main areas of study is early blood stage malaria
infection of mammalian hosts, particularly in mice as these are our
main experimental model of malaria infection. Malaria parasites
invade RBCs, killing them in the process and causing, in some
cases, severe anaemia. Some species also prefer to invade
reticulocytes over normocytes [19]. In our work, we use
mathematical models to elucidate and quantify the processes that
govern RBC and malaria parasite dynamics in infections [20]. The
standard model for RBC production in malaria infection models is
to assume that RBC growth rate is proportional to the
instantaneous difference in normal and anaemic RBC concentra-
tions (see, for example, [21,22]). Extensions to this model include a
time lag between RBC concentration and growth rate [20] and
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be sufficient to explain malaria infection data. Whether they are or
not, however, has never been adequately tested.
The aim of the work described in this paper is to gain a better
understanding of the processes that govern age structure and
dynamics of reticulocyte and RBC concentrations under anaemic
conditions in general. The results can then be used to inform our
mathematical models of malaria infections. A complicating factor
with modelling the erythropoietic system in malaria infections is
that the immune responses against the parasite are known to
interact with the erythropoietic system [24]. It is therefore easier to
elucidate erythropoietic mechanisms under anaemic conditions in
the absence of immune responses. One method of inducing
anaemia without an immune response is by administering
phenylhydrazine (PHZ). PHZ has been used for over 100 years
as a means to induce haemolytic anaemias in experimental
animals [25]. For our purposes it perturbs the RBC population
away from equilibrium. The resulting transient dynamics give us a
window into the mechanisms that govern RBC population
dynamics.
Quantitative fitting of mathematical models to data integrated
with statistical analysis is a powerful and sensitive method of
testing and comparing hypotheses and for development of
evidence based models. Here, we attempt to fit a set of
mathematical models constructed from combinations of sets of
competing hypotheses to some new experimental data from our
lab. These hypotheses reflect uncertainty in the qualitative and
quantitative nature of mechanisms that govern RBC age structure
and dynamics.
In particular, there are five mechanisms we wish to examine in
detail: the feedback from RBC concentration to production rate of
reticulocytes in bone marrow, the release of reticulocytes from
bone marrow and their subsequent ageing and clearance in the
circulation, the effect of PHZ on RBC age structure, and the effect
of blood sampling on reticulocyte proportion.
The preliminary phase of the work reported here was a trial
model development and fitting exercise to some existing
unpublished data on PHZ treated mice. These data consisted of
RBC and reticulocyte concentrations measured on day 0 and days
3–8 after PHZ treatment. Reticulocytes take about 1 to 2 days to
mature into normocytes in the circulation. In normal conditions
they are present at very low concentrations of about 1% of total
RBCs. Anaemia causes their proportion to rise dramatically as
production of erythroid progenitors in the bone marrow is up-
regulated in response to increased Epo production in the kidney.
The reticulocyte proportion is an excellent variable to test
hypotheses about erythropoietic mechanisms because cells pass
rapidly through this development stage, thus providing a much
finer scale resolution on RBC dynamics than total RBC
concentration.
The trial model fitting exercise informed the experiments
described in this paper. We used more mice (25 instead of 3) to
improve statistical inference. We sampled for longer (114 days
instead of 9) to examine return to equilibrium. We sampled twice
per day on days 5 to 9 to characterise the fast reticulocyte
dynamics that occur during this period. We measured serum Epo
concentrations to relate RBC concentration during anaemia to
production and release rates of bone marrow reticulocytes. We
quantified RBC concentration and reticulocyte count error
structures and variances to perform statistical analyses. We
performed two control experiments: one to control for blood
sampling, another to control for housing conditions in order to
prevent aggressive interactions. In the Results section we describe
these experiments, the justification and formulation of the
hypotheses we tested, and the statistical techniques we used to
test them.
Results
Experimental data
Main experiment. Two of our mice (1 and 7) were observed
in aggressive interactions after day 42. Both mice subsequently
showed typical physiological signs of aggression (reduced RBC
concentration and elevated reticulocyte proportion [26]). We
therefore did not include the data for these two mice after day 42.
The top panels of Figure 1A show the RBC concentration
dynamics over the first 14 days (left panel: individual mice, right
panel: mean62sem) The bottom panels of Figure 1A show the
reticulocyte proportion dynamics over the first 14 days (left panel:
individual mice, right panel: mean62sem). Figure 1B shows the
same over the full 114 days.
The RBC concentration dynamics show several interesting and
unexpected features. There is an initial loss of about 30% of RBCs
to about 6.5610
9 cells/ml in the first day. RBC concentration
then drops at a slower rate for another 2 to 5 days depending on
the mouse. There is a lot of variation in RBC dynamics across the
mice which causes the mean dynamics to appear flatter than in the
individual mice data. From day 6 to day 12 average RBC
concentration increases by about 0.37610
9 cells/ml/day, but then
abruptly slows by an order of magnitude to about 0.03610
9 cells/
ml/day. What appears to be unusual about these dynamics is that
this abrupt change occurs when RBC concentration is still below
equilibrium (the change occurs at an average RBC concentration
of about 8610
9 cells/ml whereas average equilibrium concentra-
tion is about 8.5610
9 cells/ml). Average RBC concentration then
rises through its equilibrium value to become polycythemic
reaching a maximum of about 9.3610
9 cells/ml on day 48.
There is a period of cell loss between days 48 and 60 which is
probably the clearance of the large cohort of RBCs induced by
anaemia reaching their maximum lifespan. Thereafter RBC
concentration appears to be in equilibrium.
The reticulocyte proportion dynamics are similarly intriguing.
Over the first 3 days there is a gradual rise in average reticulocyte
proportion from 1.5% to 10%. The rate of increase rises over the
next 2 days culminating in an average peak proportion of 30%
although there is a lot of variation between mice. Over the next 15
daysreticulocyte proportion declinesback to normalvalues butwith
a series of unusual aperiodic spikes on days 5, 6, 9, 12 and
potentially day 14. Average reticulocyte proportion shows an
unexpected drop below normal by day 26—unexpected because
RBC concentration appears to reach equilibrium values at this time
(see inset Figure 1B). This is followed by a rapid return to normal by
Author Summary
Red blood cells are made in the bone marrow and released
into the blood stream. Their population is kept at
equilibrium by complex negative feedback mechanisms.
Genetic diseases, pathogens such as malaria, and extreme
environmental changes can alter this equilibrium, either
directly by prematurely killing red blood cells or indirectly
through disrupting these feedback mechanisms. In this
paper we test competing hypotheses about the nature of
some of these mechanisms by fitting mathematical models
to experimental data. Our results give us a better
understanding of the mechanisms that govern the red
blood cell population and will improve models of diseases
that affect red blood cells.
Red Blood Cell Age Structure and Dynamics
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(approximately correlating with the slowly rising polycythemic
RBC concentration). It stays higher than normal until about day 83
after which it returns to normal. On day 113 there is again a rise.
Epo concentration. Figure 2 shows the individual mice Epo
dynamics in grey and their median in black. Because we had to
sample small volumes of blood (20 ml) our Elisa assay detection
threshold is above normal Epo concentration, hence the many
zeros in the data. The individual mice Epo data are difficult to
interpret. However, several interesting patterns emerge from the
aggregated data. Epo is generally undetectable until the third day,
and then begins to rise over the next 3 days. From days 5 to 9,
when we sampled twice per day, Epo concentration appears to
exhibit diurnal oscillations with higher concentrations measured at
8am and lower at 3pm. Our data are consistent with mice being
nocturnal, as humans have higher Epo concentrations in the
afternoon compared to the morning [27]. After day 12, Epo
concentration returns to undetectable levels. Oscillations may have
occurred on days other than 5 to 9, but because we only sampled
once per day diurnal oscillations would be undetectable.
To test if diurnal oscillations are indeed present, we performed a
bootstrap analysis both within and across mice. For each mouse
we counted the number of successive daily peaks and troughs in
the Epo data (Table 1). We then bootstrapped without
replacement each mouse’s data 10
5 times and counted the number
of peaks and troughs in each simulated data set. This constructs a
reference distribution of the number of peaks and troughs under
the null hypothesis that Epo does not oscillate daily. Comparing
the observed number of peaks and troughs to the reference
distribution, we calculate a p{value for the probability of
observing at least as many peaks and troughs than was actually
observed. These p{values are given in Table 1 (n~9). Except for
mouse 5, the evidence for diurnal oscillations is weak. However, if
we sum peaks and troughs across all mice there are 55 peaks and
Figure 2. Serum Epo concentrations. Serum Epo concentrations for individual mice (grey lines) and median (black line) of main experiment. The
two samples per day on days 5 to 9 suggest diurnal oscillations. Because we had to sample small volumes of blood (20 ml) our Elisa assay detection
threshold is above normal Epo concentration, hence the many zeros in the data.
doi:10.1371/journal.pcbi.1000416.g002
Figure 1. RBC and reticulocyte dynamics. Individual mouse data (left panels) and mean62sem (right panels) of RBC concentration (top panels)
and reticulocyte proportion (bottom panels) of the 10 mice in the main experiment for A: first 14 days, B: full 114 days. Inset expands reticulocyte
proportion from days 15 to 114.
doi:10.1371/journal.pcbi.1000416.g001
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troughs across all mice under the null hypothesis is 24 to 45
(median 34), which gives a p{value of 0.00051 (n~90), thus
strongly suggesting that Epo does oscillate diurnally. This
difference in p{values between tests on individual and aggregat-
ed data is due to the differences in statistical power of the tests
which depend on sample size.
Control experiments. One of the five mice in the group-
housed, PHZ-treated control experiment, and one of the five mice
in the group-housed, non-PHZ-treated control experiment had
anomalous RBC and reticulocyte dynamics and were removed
from the analysis.
Group and individual housing had no significant effect on RBC
concentration dynamics (compare green solid and blue dashed
lines in Figure 3 top panel). However, individual housed mice had
significantly lower reticulocyte proportions than group housed
mice and did not exhibit reticulocyte spikes (bottom panel).
In the blood sampling control experiment mice were not given
PHZ but were blood sampled as in the main experiment. Blood
sampling had no effect on RBC concentration (black dot-dashed
line in Figure 3, top panel). However, it produced a clear spike in
reticulocyte proportion in three of the four mice on day 5, with
Figure 3. Control experiments. Mean61sem of RBC concentration (top panel) and reticulocyte proportion (bottom panel) of main experiment
(red dotted lines, same as in Figure 1) sampling controls (black dot-dashed lines), individually-housed, PHZ-treated controls (blue dashed lines) and
group-housed, PHZ-treated controls (green solid lines). Lines are slightly offset from each other to reveal extent of error bars.
doi:10.1371/journal.pcbi.1000416.g003
Table 1. Epo oscillations.
mouse peaks+troughs p{value
1 3 0.70
2 5 0.26
3 7 0.065
4 7 0.073
5 9 0.014
6 7 0.064
7 2 0.93
8 4 0.40
9 6 0.10
10 5 0.19
all 55 0.00051
Testing diurnal oscillations in Epo data.
doi:10.1371/journal.pcbi.1000416.t001
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dashed line in Figure 3, bottom panel).
Models
Assessment of best fit models
Our best fitting model consisted of hypotheses A1, B1, C1, D1,
and E1. The fits to all mice are shown in Figure 4 (A: first 14 days,
B: all data, top panels: RBC concentration, bottom panels:
reticulocyte proportion). The solid lines are the median fits, and
the grey regions the 95% posterior predictive intervals.
More instructive plots for model assessment are the overlaid
standardised residuals for RBC concentration (Figure 5, top panel,
note nonlinear x{axis) and reticulocyte proportion (Figure 5,
bottom panel) of all mice in the main experiment. Inadequate
model fits are suggested by extreme residuals and serial correlation
between residuals.
The fits to RBC concentration are generally adequate but there
are two causes for concern. The RBC concentration on day 0, i.e.,
just before PHZ treatment, is underestimated (Figure 5, top panel,
t~0:0). It is clear in Figure 1B that RBC concentration on day 0 is
significantly higher (mean of 9610
9 cells/ml) than after about day
60 when presumably RBC concentration has returned to
equilibrium (8.5610
9 cells/ml). Moreover, mean RBC concentra-
tion on day 0 in the control experiments (Figure 3) is lower than in
the main experiment. These two pieces of evidence lead us to
suggest that RBC concentrations on day 0 in the main experiment
were higher than normal. This could be because of pre-experiment
conditions or transportation, although we can only speculate on
this. The second cause for concern is the serial correlation of
residuals between days 13 and 61. This corresponds to the
transition from anaemia to polycythemia and return to equilib-
rium.
The reticulocyte proportion data is not explained as well as for
the RBC concentration data. The main causes for concern are an
underestimation of the peak on day 9, and an overestimation on
day 26. Between day 19 and 26 there is a significant, if albeit small,
drop in reticulocyte proportion (Figure 1B, inset) that is not
explained in our models by reduced production or release rate of
reticulocytes caused by polycythemia. The model also overesti-
mates reticulocyte proportion on day 61 when RBC concentration
returns to equilibrium (Figure 1B). Aside from the possibility that
sampling-influences on reticulocyte proportion exist and show
temporal variation, we do not have any hypotheses to explain
these discrepancies.
Model comparison and analysis of hypotheses
In the following analysis we take as our baseline model the
model consisting of hypotheses A1, B1, C1, D1 and E1 (one of the
best fitting models). Then, taking each mechanism in turn, we
replace its corresponding baseline hypothesis with another
hypothesis of that mechanism. These models are fitted to the
data and compared to the baseline model using Bayes factors
(Table 2).
Reticulocyte production rate. There is strong evidence
(dBA2~12) that polycythemia causes a reduction in reticulocyte
production rate (hypothesis A1) rather than having no effect
(hypothesis A2). This can be seen by comparing the dynamics of
the two hypotheses. If polycythemia does not affect production
rate, RBC concentration and reticulocyte proportion immediately
return to equilibrium after the drop in RBC concentration after
day 60 (see fit of mouse 6 in Figure 6A). However, if polycythemia
does cause a reduction in production rate, the dynamics overshoot
before returning to equilibrium (Figure 4B). The mean reticulocyte
dynamics (Figure 1B) appear to support the latter rather then the
former hypothesis, and this is consistent with experimental
evidence [28,29] as discussed in the section Production rate of
bone marrow reticulocytes.
We cannot discriminate between a linear relationship between
the difference in normal and anaemic RBC concentrations and
reticulocyte production rate (A1), an exponential relationship
(dBA3~{1:8) and a sigmoidal relationship (dBA6~{1:8). This is
demonstrated in Figure 6B: over the range of RBC concentrations
(x{axis) we observe for mouse 6, the fold-change in production
rate (y{axis) varies approximately linearly even for the model
with an exponential relationship. Because we are still in the linear
region of this response curve, the sigmoidal response does not
improve the fit of the model.
We cannot discriminate between non-oscillatory (A1) and
oscillatory production rate (dBA4~0:2). This does not mean that
oscillatory production does not occur, just that any signal of
oscillations is too weak to detect in our data.
There is no support for a time lag in the feedback between RBC
concentration and reticulocyte production (dBA5~20).
Action of phenylhydrazine. Hypothesis B1 states that RBCs
present in the circulation at the moment of PHZ treatment are
immediately aged. This is consistent with our data because it
accounts for the initial loss of about 30% of RBCs within the first
day due to ageing of older RBCs past their maximum lifespan AB
(see predicted dynamics of RBC age structure of mouse 6 in
Figure 7). Hypothesis B1 also states that younger RBCs are aged
more than older RBCs. This hypothesis is consistent with our data
because it accounts for the reduction in RBC concentration from
days 2 to 5 due to higher than normal clearance rate (see
Figure 4A). (If no PHZ-induced lysis occurred during this time,
RBC concentration would rise because production rate of
reticulocytes would be greater than random clearance of RBCs.)
Hypothesis B2 states that RBCs present in the circulation at the
moment of PHZ treatment lyse at a constant rate irrespective of
their age. Thus this population decays exponentially and new
RBCs entering the circulation are not aged by PHZ. This
hypothesis is not supported (dBB2~34).
Hypothesis B3 states that PHZ lyse all circulating RBCs at a
rate proportional to its concentration and that concentration
decays exponentially over time. This hypothesis is not supported
(dBB3~42).
A problem with hypotheses B2 and B3 is that they cannot
account for the abrupt change in RBC loss between days 1 and 2.
Hypothesis B4 overcomes this by adding an initial rapid loss to
hypothesis B3. The addition of this mechanism, however, is also
not supported as dBB4~40).
Reticulocyte release from bone marrow. We cannot
discriminate between polycythemia causing a reduction in
reticulocyte release rate from bone marrow (C1) or having no
effect on (C2) release rate (dBC2~1:1).
An exponential (C1) rather than a linear (C3) relationship
between the difference in normal and anaemic RBC concentra-
tions and reticulocyte release rate is favoured (dBC3~22). This is
demonstrated in Figure 6C which shows the prediction of this
relationship for mouse 6. However, for a linear relationship, when
RBC concentration rises above the threshold B0z1=c during
polycythemia, release rate becomes 0 causing the reticulocyte
proportion to be 0 until RBC concentration drops below this
threshold; this is not observed in our data. Thus a linear
relationship may be an adequate hypothesis, but its combination
with polycythemia affecting release rate causes it not to be
supported by the data. With no evidence for or against
polycythemia causing a reduction in release rate, we must check
Red Blood Cell Age Structure and Dynamics
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not affecting release rate. This hypothesis is not supported
(dBC4~11), so we can conclude that an exponential relationship
between the difference in normal and anaemic RBC concentra-
tions and reticulocyte release rate is supported.
Clearance. Hypothesis D1 states that there is random
clearance of RBCs until they reach their maximum lifespan
(about 50 days) at which they are immediately cleared. This
hypothesis gives age distributions as shown in Figures 7 and 8.
This hypothesis is supported for two reasons. i) Under equilibrium
conditions, input rate of RBCs from bone marrow is equally
matched with clearance rate. The two mechanisms that clear
RBCs are random clearance and reaching the maximum lifespan.
Now, treatment with PHZ lyse all RBCs present at the time of
administration within about a week (see Figure 7). The post-
treatment cohort of RBCs only experience random clearance until
they reach their maximum lifespan. Therefore, until this time,
RBC input rate into the circulation is slightly higher than their
Figure 4. Model fits. Fits of best fitting model to RBC concentrations and reticulocyte proportions of individual mice of the main experiment. A:
First 14 days, and B: all data. Grey regions are 95% posterior predictive intervals (95% of data should lie within this region), and solid lines are median
solutions constructed from the 10
4 samples of the posterior distribution.
doi:10.1371/journal.pcbi.1000416.g004
Figure 5. Standardised residuals. Assessment by standardised residuals of the model consisting of hypotheses A1, B1, C1, D1, E1 fitted to all data
of the main experiment. Top panel: RBC concentration, bottom panel: reticulocyte proportion. Each cross represents the standardised residual of a
time point for an individual mouse. These have an approximately normal distribution with mean 0 and variance 1. The solid line is the mean of the
standardised residuals at each time point. The dashed lines define the approximate interval (Bonferroni corrected for multiple tests) within which we
expect the mean to lie 95% of the time if the model were true. Note the nonlinear x{axis.
doi:10.1371/journal.pcbi.1000416.g005
Red Blood Cell Age Structure and Dynamics
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observe in our data. If there were no random clearance of RBCs
(hypothesis D2) their concentration would grow by about 0.5610
9
cells/ml each day (equal to 24l) once RBC concentration had
reached equilibrium at about day 12. We observe growth an order
of magnitude lower than this at 0.03610
9 cells/ml/day. One
might argue that the resulting polycythemia could cause a
reduction in reticulocyte production rate to this level. But, to
achieve a growth rate of 0.03610
9 cells/ml/day would require an
order of magnitude reduction in reticulocyte production rate
causing reticulocyte proportion to fall to about 0.15%. This
though, is not consistent with our data which falls to just 1%
during polycythemia. The fit of hypothesis D2 (shown in
Figure 6D) confirms this, and so this hypothesis is not supported
by the data (dBD2~412). ii) If there is no immediate clearance of
RBCs of around 50 days old (hypothesis D3) we do not observe a
drop in RBC concentration at this time (Figure 6E). This
hypothesis is not supported (dBD3~188).
Reticulocyte spikes. Hypothesis E3 tests if reticulocyte spikes
can be produced intrinsically in our base model. This hypothesis is
not supported (dBE3~186). Sampling-induced reticulocytes must
therefore be produced by some unknown mechanism not explicitly
included in our model. We can test how these reticulocytes enter the
erythropoietic system. Hypothesis E2 tests if spikes are produced by
large transient increasesintheproduction rate ofreticulocytesinthe
bone marrow. This hypothesis is not supported (dBE2~40) because
the maturation age of reticulocytes is about 2–4 days, so spikes
would be observed for that length of time, instead we observe spikes
lasting for less than a day. This observation led us to suggest
hypothesis E1 in which sampling-induced reticulocytes enter
directly into the circulation.
Parameter estimates
Main experiment. The marginal distribution of the standard
deviation of RBC measurement error s, is 0.53610
9 cells/ml with
a 95% CI of 0.49 to 0.58610
9 cells/ml.
Figure 9 shows the marginal distributions of the parameters of
the model consisting of hypotheses A1, B1, C1, D1 and E1. The
base model (Equations 1–6) has six parameters, the reticulocyte
maturation time AR, the maximum reticulocyte residence time in
bone marrow AM (equal to AR{AD), the normal reticulocyte
production rate l, the normal reticulocyte release rate r, the
circulating RBC clearance rate k, and their maximum lifespan AB.
The 95% CIs of the marginal distributions of AD contain 0 and
do not go above about 10 hours (for the main experiment mice at
least, which have more data and therefore give more accurate
parameter estimates). This suggests i) that normocytes do not
remain in bone marrow (which would occur if ADv0 which we
allowed it to do), and ii) that, in normal conditions, most
reticulocytes are released as, or at most about half a day before,
they mature. This is similar to sheep [30], but not humans in
which reticulocytes appear to be released about a day before they
mature [31].
For most mice the distribution of AR is not well defined, taking
values between 2 and 5 days. It also exhibits strong negative
correlation with r (not shown) because both parameters determine
the concentration of circulating reticulocytes under normal
conditions (Equation 23). So a change in r can be compensated
for with a change in AR.
The marginal distributions of r exhibit a large variation across
mice from 7.9610
24 (95% CI: 7.1610
24, 8.5610
24)h r
21 for
mouse 9 to 0.021 (0.015, 0.026) hr
21 for mouse 4. Taken together,
the broad estimates in AR and r suggest that our data do not allow
us to precisely determine the age distribution of reticulocytes in
bone marrow and the circulation. More precise priors on one of
these parameters would improve the precision of the other. We
have not been able to find estimates for either r or AR in mice in
the literature. In humans AR is thought to be about 4 days [32],
and in rats about 3 days [18].
We took a narrow prior for maximum RBC lifespan
(AB*N 50days,1day ðÞ ) to improve identifiability of l and k.
The mean of 50 days corresponds roughly to the drop in RBC
concentration and previous estimates [33]. There is very little
difference between the marginal distributions of AB and their
prior. Therefore our data poorly identify AB.
The marginal distributions for normal RBC concentration B0,
although variable between mice, are precise. It is interesting that
the mice observed in aggressive interactions (1 and 7) have low
estimated B0.
The marginal distributions of reticulocyte production rate l and
RBC clearance rate k are correlated because reticulocyte
production rate must match RBC clearance rate in equilibrium.
The marginal distributions of l vary between 1.31610
7
(1.25610
7, 1.44610
7) cells/ml/hr for mouse 10 and 2.94610
7
(2.77610
7, 3.13610
7) cells/ml/hr for mouse 3. The marginal
distributions of k are, in general, quite broad, varying between
0.00122 (0.00112, 0.00132) hr
21 for mouse 8 and 0.00347
(0.00295, 0.00395) hr
21 for mouse 1. Mouse 1 has a high modal
clearance rate, and this is reflected in its flat RBC concentration
after day 12 (Figure 4B) rather than the increasing concentration
seen in the other mice. This is probably partly an artifact of the
shorter time series for this mouse. Mouse 3 has a similarly high
clearance rate. Again this is reflected in its relatively flat RBC
concentration after day 12. In other modelling studies RBC
clearance rate is assumed to be around 0.02 to 0.025 day
21
(0.001 hr
21) because RBC lifespan in mice is about 40 to 50 days.
The modal value of the time to delay before increased
production rate Td, is about 2.5 days. This corresponds to just
Table 2. Model comparison.
reticulocyte production rate action of PHZ reticulocyte release rate RBC clearance Reticulocyte spikes
A2 12 B2 34 C2 1.1 D2 412 E2 40
A3 21.8 B3 42 C3 22 D3 188 E3 186
A4 0.2 B4 40 C4 11
A5 20
A6 21.8
Comparison of each hypothesis against the best fitting model consisting of hypotheses A1, B1, C1, D1 and E1. Decibans .10 are strong evidence against a hypothesis
(Equation 26).
doi:10.1371/journal.pcbi.1000416.t002
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(Figure 1) and when Epo concentrations rise above detection
(Figure 2). However, it appears that a delay is only required to
adequately explain the data of some of the mice; the 95% CI of Td
in the majority of mice contains 0. This is probably because only 2
or 3 data points provide estimates for Td.
The marginal distributions for the scaling factor between
anaemia and fold-increase in RBC production rate a vary between
0.28610
210 (0.21610
210, 0.37610
210) (cells/ml)
21 for mouse 3,
and 3.3610
210 (3.0610
210, 3.5610
210) (cells/ml)
21 for mouse 4.
The PHZ-induced change in age of RBCs of age 0, A1, are well
defined within mice and vary between 41 and 45 days across mice.
The PHZ-induced change in age of RBCs of age AB, A2, is less
well defined; for most mice it is between 2 and 9 days with a mean
of roughly 3 days.
The marginal distributions for the scaling factor between
anaemia and fold-increase in reticulocyte release rate c vary
between 0.70610
29 (0.65610
29, 0.74610
29) (cells/ml)
21 for
mouse 10 and 2.24610
29 (1.74610
29, 2.93610
29) for mouse 4.
The maturation time of sampling-induced reticulocytes in the
circulation AS is quite variable, from as little as 4 hours in mice 9
and 10, up to about 2 days in other mice. The marginal
distribution for mouse 4 is quite broad, most likely reflecting the
lack of reticulocyte spikes for this mouse (Figure 4B). The fold-
increase in sampling-induced reticulocyte production rate e is quite
broad varying between 2.5 (1.9, 3.2) for mouse 1 and 12 (11, 13)
for mouse 10.
Housing control experiments. The marginal distributions
of the PHZ-treated control mice are shown in Figure 9. Most of
the parameters have similar distributions as the main experiments,
although some are slightly wider due to fewer data for these mice.
The most striking difference in parameter estimates is the PHZ-
induced ageing parameter A1.
Initially we used the same priors for the control experiments as
we did for the main experiment. We found that RBC clearance
rate k, was not well defined in control mice (data not shown)
because the RBC dynamics had not returned to equilibrium by the
end of these experiments. This affected the estimation of the PHZ-
induced ageing parameters A1 and A2 because these depend on
the equilibrium RBC age distribution which depends on k.A
potential difference between the main and the control experiments
could have been the efficacy of the PHZ administered because
these experiments were done with different batches of PHZ. Such
a difference could affect the PHZ-induced ageing of RBCs.
Therefore, to be able to compare PHZ-induced ageing between
the main and control experiments we based the prior of k for the
control experiments on its estimated marginal distributions from
the main experiment. The prior we chose was N(0.0015, 0.0005).
The posterior estimates shown in Figure 9 clearly demonstrate that
Figure 6. Hypothesis testing. A: Hypothesis A2: polycythemia not reducing production rate does not capture RBC and reticulocyte dynamics after
day 60 (shown for mouse 6). B: Hypothesis A1: Production rate varies almost linearly with anaemia even allowing for an exponential relationship
(shown for mouse 6). C: Hypothesis C1: reticulocyte release rate is exponentially related to anaemia (shown for mouse 6). D: Hypothesis D2: fixed RBC
lifespan does not capture RBC dynamics. E: Hypothesis D3: unlimited RBC lifespan does not capture RBC dynamics.
doi:10.1371/journal.pcbi.1000416.g006
Figure 7. Predicted RBC age distributions. Prediction of circulating
RBC age distribution just before, just after, and at various days after,
PHZ treatment for mouse 6. The black line shows the estimated median
age distribution and the grey region the 95% posterior predictive
interval calculated from the samples of the posterior distribution of the
model consisting of hypotheses A1, B1, C1, D1, E1. On day 0 the age
distribution is in equilibrium made up of about 1% reticulocytes. All
RBCs are aged with PHZ treatment causing an approximately 30% drop
in RBC concentration, and a higher than normal clearance rate for about
7 days. Anaemia induces early release of reticulocytes from bone
marrow (day 5) and increased reticulocyte production. Random
clearance of RBCs prevents a large drop in RBC concentration about
50 days after PHZ treatment (day 40). The system returns to equilibrium
after about day 60.
doi:10.1371/journal.pcbi.1000416.g007
Figure 8. Schematic of RBC age distributions. Schematic of age
distribution of reticulocytes in bone marrow and reticulocytes and
normocytes in the circulation under normal equilibrium conditions.
Reticulocytes are produced at a rate l in bone marrow. These are
released into the circulation at a rate r. All reticulocytes are released by
age AM, and have a maturation time of AR hours. RBCs are randomly
cleared at a rate k and have a maximum lifespan of AB days. Not to scale.
doi:10.1371/journal.pcbi.1000416.g008
Red Blood Cell Age Structure and Dynamics
PLoS Computational Biology | www.ploscompbiol.org 11 June 2009 | Volume 5 | Issue 6 | e1000416A1 is smaller for most mice in the control experiments. We
therefore suggest that the efficacy of the PHZ administered in
these experiments was weaker than for the main experiment. This
could explain why mice in the main experiment were more
anaemic and had higher reticulocyte proportions than control
mice (Figure 3).
Parameters AS and e determine the duration and magnitude of
the spikes in reticulocyte proportion. For mouse 4 in the main
experiment and all the individually housed mice, the 95% CIs of
the product of these two parameters contains 0. This correlates
with the observation that these mice showed weak or no spikes.
An outlier in mouse 8?
During day 7, the reticulocyte proportion in mouse 8 dropped
dramatically to almost normal levels (0.036%, Figure 4A), before
rapidly rising again. This could be because the blood smear was
mixed up with another, although we are certain this did not occur.
It could be an anomalous count, although the probability of
counting just 18 reticulocytes in 500 RBCs instead of around 117
reticulocytes (which is the average of the other 9 mice at this time)
is unlikely (Binomial 18;p~18=117,N~500
  
~3|10{35). Or it
could be a real phenomenon. None of our models capture this
behaviour. Instead we have assumed in the above analysis, and for
this mouse only, that the release rate of reticulocytes from time Tr1
to Tr1zTr2 returns to baseline r. The marginal distributions for
Tr1 is 126 (121, 131) hrs and for Tr2 64 (54, 78) hrs (Figure 9). We
have tried allowing a drop in production rate but with no success.
We have no explanation for why a temporary return to baseline
release rate may have occurred only in this mouse.
Discussion
The aim of this paper was to synthesise ideas from previous
experimental data and the mathematical modelling literature with
new data in order to test old and new hypotheses about mechanisms
that govern reticulocyte and RBC age structure and population
dynamics inbone marrow and the circulationof mice. In contrast to
previous model fitting studies we quantified measurement error.
This allowed us to perform model fitting, model testing, model
comparisonandparameterestimation underaBayesianframework.
We tested multiple hypotheses that reflect uncertainty in erythro-
poietic mechanisms. Some of the hypotheses do not adequately
explain the data and others do. So although we can rule out certain
hypotheses, we are left with some that our data cannot discriminate
between. This therefore suggests which mechanisms should be
explored with further experiments and modelling.
The picture of the erythropoietic system emerging from this
synthesis of data and modelling is as follows. Under normal
conditions (see Figure 8) reticulocytes are produced at about 10
7
cells/ml serum/hour in bone marrow. Reticulocytes mature for
between 2–4 days with limited release (with rate constant of about
10
23 hr
21) into the circulation (we estimate about 2–5% of
reticulocytes are in the circulation with the rest in bone marrow).
Once matured into normocytes, any cells remaining in the bone
marrow are immediately released into the circulation. RBCs
undergo random clearance with a rate constant of about
0.002 hr
21 independent of age, which causes a negative
exponential age distribution. On reaching about 50 days old
there is rapid clearance of any remaining RBCs (we cannot
estimate this rate with our data).
Figure 9. Parameter estimates. Marginal distributions of parameters of model consisting of hypotheses A1, B1, C1, D1, and E1 for main, and
housing control experiments.
doi:10.1371/journal.pcbi.1000416.g009
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rather than kill RBCs. Older RBCs are aged past their maximum
lifespan and are immediately cleared causing a rapid loss of RBCs
within 24 hrs. Younger RBCs, which are affected more than older
RBCs by PHZ, are not immediately cleared, but cause a higher
than normal clearance rate for several days until all are lost (see
upper three panels in Figure 7). Serum Epo response is delayed for
about 3 days, and may correlate with a delay in increased
production of reticulocytes in some mice. We have also discovered
that Epo appears to exhibit pronounced diurnal oscillations at least
during anaemia, but we cannot tell if this causes oscillations in
reticulocyte production rate. Production rate of reticulocytes is
linearly and negatively correlated with RBC concentration—at
least across the range of concentrations we observed. On
treatment with PHZ, release rate of reticulocytes from bone
marrow increases immediately and dramatically. We estimate that
at maximum anaemia, between 35 to 95% of reticulocytes were in
the circulation. After about 12 days of increased production, RBC
concentration overshoots normal levels causing polycythemia.
This results in a lower than normal reticulocyte production rate
causing a lower than normal reticulocyte proportion. Normal
equilibrium conditions are restored after the PHZ-induced cohort
of RBCs reach the end of their lifespan. Blood sampling caused
aperiodic and pulsed release of reticulocytes into the circulation in
mice housed in groups but did not in mice housed individually.
Reticulocytes comprising spikes appear to have a different
developmental pathway than normal reticulocytes because their
mechanism of release into the circulation is different.
Erythropoietin mediates the negative feedback between haemo-
globin concentration in the circulation and apoptosis of erythroid
progenitor cells that develop into cell-cycle arrested reticulocytes
[34]. We initially included erythroid progenitors in our model and
assumed that they were irreversible committed to differentiate into
reticulocytes. Under this assumption, we found that all the
parameters that governed their age distribution were unidentifiable
given the data we had. All we were able to quantify was the rate at
which erythroid progenitors differentiate into reticulocytes in bone
marrow (l) and how this rate is modified by RBC concentration
(gt ,Bt ðÞ ðÞ ). Including erythroid progenitors in the model did not
improve its fit. In contrast, [9] assume that erythroid progenitors
take 4 days to mature but do not estimate its value from model
fitting, and [15] estimate their maturation time in rats to be 43 hrs
with a coefficient of variation of 7.5% by fitting to data.
Although our model can adequately explain most of the data,
where it does not, raises some interesting questions. For example,
by what mechanism does blood sampling induce spikes in
reticulocyte counts? What causes the temporal pattern of spikes
and why were they synchronous in the ten main experimental
mice but not in the control mice? Why were spikes less apparent
and reticulocyte proportion lower in individually housed mice
compared to grouped mice? What caused the return to baseline
release rate in mouse 8? Why is there a 3 day delay in increased
serum Epo concentration? Also our model does not appear to
adequately explain RBC and reticulocyte dynamics between days
13 to 61 when RBC concentration overshoots its normal levels and
becomes polycythemic. We hope to address theses questions with
further experimental and modelling work.
Methods
Ethics statement
All experimental procedures were regulated and carried out
under the U.K. Home Office Animals (Scientific Procedures) Act,
1986.
Experiments and data collection
Adult male MF1 mice were used for all experiments for two
reasons: their large size reduces the effect of blood sampling their
erythropoietic state, and their docile and non-aggressive nature
reduces the chance that stressful interactions when housed in
groups affects RBC and reticulocyte dynamics [35,36].
At each sampling time point we took 2 ml blood to measure
RBC concentration, we took a blood smear with approximately
1 ml blood to measure reticulocyte proportion and we took 20 ml
blood to measure serum Epo concentration. We diluted 1:40,000
the 2 ml blood sample and measured RBC concentration by
coulter counter. We stained blood smears with 10% Giemsa in
pH 7.2 buffer and estimated reticulocyte proportion by counting
the number of reticulocytes observed in at least 500 RBCs by light
microscopy.
We measured Epo concentration using an Elisa adapted from
[37] to measure Epo concentration from small blood samples and
thus permit repeat sampling of each mouse. We collected 20 mlo f
blood in 5 ml of heparin for each sample point. We centrifuged this
at 13,000 rpm for 3 minutes, and collected and stored the serum
at 280uC. We prepared the Elisa plates by adding 50ml=well of
4 mg/ml rat anti-mouse Epo IgG1 antibody (BD, 554651) before
incubation at 4uC overnight. We washed the plates with 0.1%
Tween 20 in PBS and blocked them with 250ml=well of 1%
Bovine Serum Albumin (BSA) for 1 hr at room temperature. We
loaded the plates with rmEpo (Roche, 112769640010) standards in
a2 6 dilution series (500-0.98 mU/ml). We defrosted the serum
samples and diluted 20 ml of each in 80 ml of blocking buffer which
we then used to make a 26dilution series for each sample. We left
the plates to incubate overnight at 4uC. After washing 3 times, we
added, at 10 mg/ml, 50ml=well of polyclonal rabbit anti-hEpo
antibody (R&D, AB286NA) and incubated them at room
temperature for 1 hr before washing a further 3 times. We
incubated the plates with 50ml=well of HRP-conjugated goat anti-
rabbit IgG (Bio-Rad, 1708241) at a 1:3000 dilution in blocking
buffer at room temperature for 1 hr. We detected the bound
conjugate by adding 0.1ml/well of ABTS substrate with 0.036%
hydrogen peroxide and developed for 20 minutes before reading
at wavelength 405 nm with 595 nm as reference. We obtained the
concentrations of Epo in the serum samples by comparison with
values of the rmEpo standard curve.
The main experiment consisted of 10 mice treated with 40 mg/
kg PHZ intraperitoneally and housed together. Their blood was
sampled 35 times: from just prior to PHZ administration to 113
days post treatment. We measured RBC concentration and
reticulocyte proportion for each sampling point and measured
Epo concentration up to day 42. As a temporal control for blood
sampling, we took the 20 ml of blood required for Epo
measurement at each sample point for all mice in all experiments
whether or not it was used for Epo measurement. As our trial
experiment on PHZ-treated MF1 mice demonstrated fast
reticulocyte dynamics from days 5 to 9 post PHZ treatment we
sampled twice per day during this period to ensure improved
model discrimination. We took samples daily for days 0 to 4
inclusive and days 10 to 14 inclusive and weekly for another 13
weeks. We took samples at 9am, and, for twice daily sampling, at
3pm. We carried out additional experiments to investigate any
effects of blood sampling and group housing on erythropoietic
dynamics. This involved monitoring reticulocyte proportion and
RBC concentration in three groups of five mice: group-housed,
non-PHZ-treated mice, group-housed, PHZ-treated mice, and
individually-housed, PHZ-treated mice. Sampling frequency was
the same as for the main experiment except that samples were only
collected up to day 14.
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We use a two-compartment, continuous-time, age-structured
formalism for our models. The two compartments are bone
marrow and the circulation. We model reticulocyte concentration
in bone marrow and the circulation (with conversion to a
proportion of total RBC concentration for model fitting) and
RBC concentration in the circulation. In this section, we describe
the mathematical formulation of the base model. We then consider
a range of competing hypotheses that reflect uncertainty in the
mechanisms of the erythropoietic system.
The youngest bone marrow cells we consider are erythroid
progenitor cells that have just differentiated into cell-cycle arrested
reticulocytes (Figure 8). We define their age to be 0. Under normal
equilibrium conditions we assume that their production rate is l
with units of cells/ml blood serum/hr. We assume that
reticulocyte maturation time is AR hours.
The production rate of reticulocytes is mediated by erythropoi-
etin (Epo), a glycoprotein hormone produced in the kidney and
other organs [38,39]. Epo controls erythroid progenitor growth by
retarding their DNA breakdown and preventing apoptosis [34]. It
was our intention to construct models that related reticulocyte
production (from erythroid progenitors) to serum Epo concentra-
tion which in turn was related to the difference between normal
and anaemic circulating RBC concentrations. However, on
analysis of our Epo data, we concluded that we could not have
absolute confidence in the precision of the Elisa data, possibly due
to the small volumes of blood analysed and the accuracy of
interpolation from our standard curve. Moreover, we had no
quantitative estimate of the experimental error in Epo concentra-
tion so we could not assess the adequacy of a model fit to it.
Instead we directly relate reticulocyte production rate to the
difference between normal and anaemic circulating RBC
concentrations and neglect serum Epo concentration as an
intermediate regulator.
We therefore assume that under anaemic conditions reticulo-
cyte production rate l, is multiplied by a function gt ,Bt ðÞ ðÞ which
is the fold-change in reticulocyte production rate compared to
normal. Time since PHZ administration is t with units of hours
and Bt ðÞis the circulating RBC concentration at time t with units
of cells/ml.
In normal conditions in humans, reticulocytes mature for about
3 days in bone marrow, are released into the circulation, and
complete maturation within a day [32]. As RBC concentration
falls, maturation time remains constant at about 4 days but
residence time in bone marrow decreases linearly with RBC
concentration [32]. Other studies have demonstrated that
reticulocytes in humans, sheep and mice are released early from
bone marrow in phlebotomy-induced anaemia [13,16,32] and
intravenous dosing with recombinant human Epo [31].
Immature and mature reticulocytes can be differentiated by
their RNA content because they lose RNA as they mature. Data
from humans [31] show that, in normal conditions, about 5% of
reticulocytes in the circulation are immature (using the definition
of maturity in [31]) and 95% are mature. Stimulus of
erythropoiesis, in this case by an injection of Epo, caused an
immediate release of immature reticulocytes from bone marrow
into the circulation. There was no increase of mature reticulocytes
for another 3 days. This suggests the inclusion of the following two
processes in our model. i) In normal conditions, most immature
reticulocytes remain in bone marrow with some small amount of
migration into the circulation. ii) Mature reticulocytes are released
into the circulation before maturation into normocytes. We
formulate these processes as follows. In normal conditions we
assume that bone marrow reticulocytes are released into the
circulation at a rate r. As for reticulocyte production rate, we
model the direct relationship between the difference in normal and
anaemic RBC concentrations and release rate, ignoring the
intermediate regulation by Epo. Thus we assume that r is
modified under anaemic conditions by the function rBt ðÞ ðÞ which
is the fold-change in reticulocyte release rate compared to normal.
We assume that there is a maximum residence time
AM~AR{AD, of cells in the bone marrow. If ADw0 all
reticulocytes exit the bone marrow before maturation, and if
ADv0 reticulocytes mature into normocytes before entering the
circulation Figure 8.
Let ma ,t ðÞ be the age distribution of bone marrow reticulocyte
(plus normocyte if ADv0) concentration with units of cells/ml/
hour. The partial differential equation describing its rate of change
is given by
L
La
ma ,t ðÞ z
L
Lt
ma ,t ðÞ ~
{ rrBt ðÞ ðÞ zd a{AM ðÞ ðÞ ma ,t ðÞ for0ƒaƒAM
ð1Þ
where a is cell age. The left-hand-side (LHS) of Equation 1
describes cell ageing, the first term on the right-hand-side (RHS)
describes release of cells between ages 0 and AM from bone
marrow into the circulation and the second term (a Dirac-delta
function) describes release of any remaining cells at age Am.
Let ba ,t ðÞ be the age distribution of circulating RBC
concentration (reticulocytes plus normocytes) with units of cells/
ml/hour. RBCs are cleared by phagocytosis in the spleen, liver
and bone marrow. Cohort labelling with radioiron in mice
suggests that RBCs are randomly cleared at an age-independent
rate, with negligible RBCs surviving more than about 50 days
[33]. In humans, however, there appears to be little clearance
before about 120 days with rapid clearance thereafter [40]. We
combine these two pieces of evidence and assume that, up to AB
days old (about 50 days), RBCs are randomly cleared at a
relatively slow rate k. After that, clearance rate accelerates. With
our data we can estimate k, but we cannot quantify the
acceleration in clearance rate. We therefore assume that RBCs
have a maximum lifespan of AB hours; in other words, any RBCs
that reach the age of AB are immediately cleared.
The partial differential equation describing the rate of change of
circulating RBC age distribution is given by
L
La
ba ,t ðÞ z
L
Lt
ba ,t ðÞ ~ rrBt ðÞ ðÞ zd a{AM ðÞ ðÞ ma ,t ðÞ
{ kzd a{AB ðÞ ðÞ ba ,t ðÞ for 0ƒaƒAB
ð2Þ
The LHS of Equation 2 describes RBC ageing, the first two terms
on the RHS describe release of bone marrow cells into the
circulation, and the last two terms describe RBC random
clearance and immediate clearance at their maximum lifespan
respectively.
The boundary conditions for Equations 1 and 2 at a~0 are the
production rate of bone marrow reticulocytes and 0 (because
RBCs enter via the bone marrow) respectively, i.e. (see Figure 8),
m 0,t ðÞ ~gt ,Bt ðÞ ðÞ l ð3Þ
b 0,t ðÞ ~0 ð4Þ
Note that, in normal conditions r~g~1.
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circulating RBCs Bt ðÞ(reticulocytes plus normocytes), are
Rt ðÞ ~
ðAR
0
ba ,t ðÞ da ð5Þ
Bt ðÞ ~
ðAB
0
ba ,t ðÞ da ð6Þ
All variables, functions and parameters are listed in Table 3. In the
following sections we formulate the hypotheses we will test.
Production rate of bone marrow reticulocytes. Epo
production is known to increase exponentially with falling RBC
concentration [41,42], but the functional relationship between
serum Epo concentration and production rate is not known.
Sigmoidal [1,9] and linear [11] responses have been used in
previous models. We considered three hypotheses which relate
RBC concentration to reticulocyte production rate: exponential
(hypothesis A1), linear (hypothesis A3) and sigmoidal (hypothesis
A6). See below for their formulation.
When oxygen supply exceeds demand, as for instance during
repeated transfusions of RBCs causing polycythemia (higher than
normal RBC concentration), circulating reticulocyte concentration
decreases due to production of fewer reticulocytes in bone marrow
Table 3. Variables and parameters used in the mathematical models.
Independent variables
a age Hr
t time Hr
Dependent variables
ma ,t ðÞ bone marrow cell age distribution cells/ml/hr
ba ,t ðÞ circulating RBC age distribution cells/ml/hr
Bt ðÞ circulating RBC concentration cells/ml
Rt ðÞ circulating reticulocyte concentration cells/ml
Functions
gt ,Bt ðÞ ðÞ anaemia-induced fold-change in reticulocyte production rate over normal
rBt ðÞ ðÞ anaemia-induced fold-change in reticulocyte release rate over normal
Parameters
B0 normal circulating RBC concentration, equal to B 0 ðÞ cells/ml
R0 normal circulating reticulocyte concentration, equal to R 0 ðÞ cells/ml
AR reticulocyte maturation time hr
AM maximum residence time in bone marrow hr
AD equal to AR{AM hr
AB maximum RBC lifespan hr
r normal bone marrow reticulocyte release rate into circulation hr
21
l normal bone marrow reticulocyte production rate cell/ml/hr
k clearance rate of circulating RBCs hr
21
a scaling factor between difference in normal and anaemic RBC concentrations and reticulocyte production rate (cells/ml)
21
a
0 maximum fold-change in reticulocyte production rate over normal
Td delay from PHZ treatment to increased reticulocyte production rate hr
t time lag in reticulocyte production rate hr
y amplitude of oscillations of reticulocyte production rate
w initial phase of oscillations of reticulocyte production rate radians
A1 PHZ-induced change in age of RBCs of age 0 hr
A2 PHZ-induced change in age of RBCs of age AB hr
b, b1 PHZ-induced RBC lysis rate hr
21
b2 decay rate of PHZ hr
21
b3 proportion of RBCs lysed just after PHZ treatment
c scaling factor between difference in normal and anaemic RBC concentrations and reticulocyte release rate (cells/ml)
21
AS sampling-induced reticulocytes’ maturation time hr
e fold-increase in sampling-induced reticulocytes’ production over normal
Ti, i~1,:::,n time when reticulocyte spike i starts hr
Di, i~1,:::,n duration of reticulocyte spike i hr
n number of reticulocyte spikes
doi:10.1371/journal.pcbi.1000416.t003
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(hypothesis A1), or has no effect on (hypothesis A2), production rate.
There is evidence of diurnal oscillations in circulating
reticulocyte concentration and mitotic activity in bone marrow
in rats and mice [43]. Our data and other work [44] suggest
diurnal oscillations in Epo concentration in mice. It is therefore
suggestive that diurnal oscillations in Epo could cause oscillations
in production rate. We therefore tested two hypotheses: with
(hypothesis A4), and without (hypothesis A1), diurnal oscillations
in production rate.
In our data, two pieces of evidence suggest there may be a delay
of several days from administration of PHZ to increased production
rate: the rapid rise in reticulocyte proportion around day 3
(Figure 1A and 1B), and Epo concentration generally below
detectability until about day 3 then rapidly rising (Figure 2).
Hypothesis A1 tests this idea by only allowing increased production
after some time Td. Hypothesis A5, however, tests another idea that
may explain the data: production rate at time t depends on RBC
concentration at some earlier time t{t. This idea has been used in
other modelling studies (e.g., [20]). The mathematical formulations
of all these hypotheses are detailed below.
Hypothesis A1 Increased reticulocyte production is delayed
after PHZ treatment. Production rate depends instantaneously
and exponentially on the difference between normal and anaemic
RBC concentrations.
This means g (the anaemia-induced fold-change in reticulocyte
production rate over normal) in Equation 1 has the form
gt ,Bt ðÞ ðÞ ~
1i f tvTd
exp a B0{Bt ðÞ ðÞ ðÞ if t§Td
 
ð7Þ
where Td is the delay between PHZ administration and increase in
production rate, a is a scaling factor and B0~B 0 ðÞ , the normal
RBC concentration.
Hypothesis A2 As hypothesis A1, but production rate remains
normal during polycythemia (Bt ðÞ wB0).
This means g has the form
gt ,Bt ðÞ ðÞ ~
1i f tvTd or Bt ðÞ wB0
exp a B0{Bt ðÞ ðÞ ðÞ if t§Td and Bt ðÞ ƒB0
 
ð8Þ
Hypothesis A3 As hypothesis A1, but production rate depends
linearly on the difference between normal and anaemic RBC
concentrations.
This means g has the form
gt ,Bt ðÞ ðÞ ~
1i f tvTd
max 0,1za B0{Bt ðÞ ðÞ fg if t§Td
 
ð9Þ
The maximum value is taken to prevent production rate becoming
negative during polycythemia.
Hypothesis A4 As hypothesis A1, but reticulocyte production
rate exhibits diurnal oscillations
This means g has the form
gt ,Bt ðÞ ðÞ ~ 1zysin
2p
24
tzw
     
|
1i f tvTd
exp a B0{Bt ðÞ ðÞ ðÞ if t§Td
( ð10Þ
where y is the amplitude and w the initial phase of the oscillations.
Hypothesis A5 As hypothesis A1, but with a lag in the
feedback between reticulocyte production rate and RBC concen-
tration instead of a delay from PHZ administration to increased
production rate.
This means g has the form
gt ,Bt {t ðÞ ðÞ ~exp a B0{Bt {t ðÞ ðÞ ðÞ ð 11Þ
where t is lag time.
Hypothesis A6 As hypothesis A1, but production rate depends
sigmoidally on the difference between normal and anaemic RBC
concentrations.
This means g has the form
gt ,Bt ðÞ ðÞ ~
1i f tvTd
a
0
1z a
0{1 ðÞ exp {a1 B0{Bt ðÞ ðÞ ðÞ if t§Td
(
ð12Þ
where a
0
is the maximum fold-change in reticulocyte production
rate over normal.
Effect of phenylhydrazine. Phenylhydrazine (PHZ) has
been used for over 100 years to induce haemolytic anaemias in
experimental animals [25] through RBC lysis. Remarkably,
studies on whether PHZ alters the age distribution of RBCs
have not been previously undertaken. We test four hypotheses for
the action of PHZ on circulating RBCs; we assume it has no effect
on bone marrow reticulocytes.
It has been shown in rabbits that PHZ is eliminated slowly from
the body; 60% of a 50 mg/kg dose is removed in 10 days [45].
However, it is unknown if PHZ lyse only those RBCs present in
the circulation when it is administered (hypothesis B2) or if in
addition it lyses RBCs that enter the circulation after it is
administered (hypothesis B3). For hypothesis B2 we assume that
RBCs are lysed at a constant rate, and for hypothesis B3 we
assume that lysis rate is proportional to PHZ concentration which
decays exponentially over time.
These two hypotheses cause a smooth, exponential decay in
RBC concentration. Our data suggest, however, an abrupt change
from a fast to a slow lysis rate sometime before 24 hrs post PHZ
administration (Figure 1A). We test this hypothesis (hypothesis B4)
by removing a proportion of RBCs from the circulation just after
PHZ administration.
PHZ is known to react with haemoglobin to produce free
radicals that cause peroxidation of RBC lipid membranes leading
to lysis [46]. This led us to consider the hypothesis that PHZ does
not kill RBCs outright, but prematurely ages them (hypothesis B1).
In addition, we consider the hypothesis that PHZ might age
younger RBCs more than older RBCs, perhaps because younger
RBCs are more metabolically active and thus more vulnerable to
oxidative damage. The mathematical formulations of these
hypotheses are detailed below.
Hypothesis B1 RBCs present in the circulation when PHZ is
administered are prematurely aged. RBCs entering the circulation
after PHZ treatment are not aged by PHZ. The change in a
RBC’s age is linearly correlated with its age at time of treatment.
Just after t~0, RBC ages are transformed to
a?azA1{
A1{A2
AB
a ð13Þ
where A1 i st h ec h a n g ei na g eo fR B C so fa g e0 ,A2 is the change in
a g eo fR B C so fa g eAB,a n dAB is the maximum RBC lifespan. Any
RBCs aged past the maximum lifespan are immediately cleared.
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administered lyse at a constant rate. RBCs entering the circulation
after PHZ treatment are not aged.
Equation 2 is modified by addition of the term
{
bba ,t ðÞ if a§t
0 otherwise
 
ð14Þ
where b is the PHZ-induced lysis rate.
Hypothesis B3 All RBCs in the circulation (pre and post PHZ
treatment) lyse at a rate proportional to PHZ concentration which
itself decays exponentially.
Equation 2 is modified by addition of the term
{b1exp {b2t ðÞ ba ,t ðÞ ð 15Þ
where b1 is the initial PHZ-induced lysis rate, and b2 the decay
rate of PHZ.
Hypothesis B4 As hypothesis B3, but with immediate lysis of a
proportion of RBCs present when PHZ is administered.
Equation 2 is modified as for hypothesis B3. In addition, just
after t~0, RBC age distribution is transformed to
ba ,0 ðÞ ? 1{b3 ðÞ ba ,0 ðÞ ð 16Þ
where b3 is the proportion of RBCs lysed just after treatment.
Reticulocyte release from bone marrow. We test if release
rate is linearly (hypothesis C3) or exponentially (hypothesis C1)
related to the difference in normal and anaemic RBC
concentrations. We test if polycythemia reduces (hypothesis C1)
or has no effect on (hypothesis C2) release rate. Finally we test the
combined hypotheses of a linear relationship and polycythemia
having no effect on release rate (hypothesis C4).
Hypothesis C1 Reticulocyte release rate from bone marrow
depends instantaneously and exponentially on the difference
between normal and anaemic RBC concentrations.
This means r (the anaemia-induced fold-change in reticulocyte
release rate over normal) in Equations 1 and 2 has the form
rBt ðÞ ðÞ ~exp c B0{Bt ðÞ ðÞ ðÞ ð 17Þ
where c is a scaling factor.
Hypothesis C2 As hypothesis C1, but polycythemia does not
reduce release rate.
This means r has the form
rBt ðÞ ðÞ ~
1i f Bt ðÞ wB0
exp c B0{Bt ðÞ ðÞ ðÞ if Bt ðÞ ƒB0
 
ð18Þ
Hypothesis C3 As hypothesis C1, but release rate depends
linearly on the difference between normal and anaemic RBC
concentrations.
This means r has the form
rBt ðÞ ðÞ ~max 0,1zc B0{Bt ðÞ ðÞ fg ð19Þ
The maximum is taken to prevent the release rate becoming
negative during polycythemia.
Hypothesis C4 As hypothesis C3, but polycythemia does not
reduce release rate.
This means r has the form
rBt ðÞ ðÞ ~
1i f Bt ðÞ wB0
1zc B0{Bt ðÞ ðÞ if Bt ðÞ ƒB0
 
ð20Þ
Clearance of circulating RBCs. We wish to test if RBCs are
cleared randomly and independently of age (hypothesis D3), or if
they are all cleared at a fixed age (hypothesis D2), or if they are
cleared randomly up to a fixed age and then cleared immediately
(hypothesis D1).
Hypothesis D1 RBCs are cleared at rate k until age AB, any
remaining are then immediately cleared.
No modification to Equation 2 is required.
Hypothesis D2 No clearance of RBCs until they reach age
AB, they are then rapidly cleared.
This means k~0 in Equation 2.
Hypothesis D3 RBCs are cleared at rate k.
This means AB?? in Equation 2.
Production of reticulocyte spikes. Spikes in reticulocyte
proportion have not previously been documented in the literature.
This could be because sampling is rarely undertaken more
frequently than once per day, so a spike lasting for less than
24 hours would not be observed. Or it could be because spikes
have previously been interpreted as experimental noise.
Our control experiments strongly suggest that reticulocyte
spikes are induced by blood sampling and not by any intrinsic
response to anaemia. Moreover, we have found no biologically
plausible mechanism that can produce reticulocyte spikes at non-
periodic intervals. Therefore, we model them phenomenologically
(that is, without any mechanistic explanation) as a series of pulsed
inputs of reticulocytes either into bone marrow (hypothesis E2) or
directly into the circulation (hypothesis E1). We also test if our base
model can provide an adequate fit to our data without including
reticulocyte spikes (hypothesis E3). This phenomenological model
can be thought of as a filter, filtering out nuisance data in order to
extract information from the underlying data. Nevertheless, these
spikes do change RBC and reticulocyte dynamics, so we may be
able to make inferences about their mechanistic cause.
Hypothesis E1 Sampling-induced reticulocytes enter directly
into the circulation. Their production rate and maturation time
may be different to normal reticulocytes.
Equation 2 is modified by the additional term
z
eld a{ AR{AS ðÞ ðÞ if TiƒtvTizDi fori~0,:::,n
0 otherwise
 
ð21Þ
where el is the production rate of sampling-induced reticulocytes,
AS is their maturation time in the the circulation, d : ðÞis the Dirac
delta function, Ti is the time after PHZ administration that spike i
appears, Di is the duration of spike i and n the number of spikes.
Hypothesis E2 Sampling-induced reticulocytes are produced
in bone marrow. Their maturation time is the same as normal
reticulocytes but their production rate may be different.
Equation 3 is modified by the additional term
z
el if TiƒtvTizDi fori~0,:::,n
0 otherwise
 
ð22Þ
Hypothesis E3 No sampling-induced reticulocytes.
No modifications to Equations 1 and 3 are required.
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Measurement error in RBC concentration. Close to the
end of the main experiment we used seven of the mice to
determine the error structure and variance of the RBC
concentration measurements. For each mouse, four 2 ml blood
samples were taken and coulter counted. If the measurement error
variance is s2, then the difference between any pair of samples
from a mouse has expectation 0 and variance 2s2. For each mouse
there are two independent pairs, and therefore, with 7 mice, 14
independent pairs in total. The errors were found to be normally
distributed (Anderson-Darling test pv0:05 [47]) and the estimate
of s was 0.61610
9 (95% CI: 0.44610
9, 0.84610
9) cells/ml.
We further refined our estimate of s using the main experiment
data during the model fitting. Our prior on s was taken as
normally distributed with mean 0.61610
9 and standard deviation
0.1610
9 (based on the estimated 95% CI of s).
Measurement error in reticulocyte counts. For each
smear, the number of reticulocytes and normocytes were counted
from a random sample of 500 RBCs (except at the first time point
for mice 1 and 2 when 2000 RBCs were counted, and at the first
time point fortheother mice when 1000 RBCs werecounted). Ifthe
true proportion of reticulocytes in mouse m at time t is pmt then the
number of counted reticulocytes Rmt, is Binomially distributed with
parameters pmt and Cmt~500, 1000 or 2000.
Model fitting and parameter estimation. The models
were numerically implemented in discrete time with a timestep of
1 hr. We used an Evolutionary Monte Carlo (EMC) method [48]
to sample the posterior density. Parameters were estimated
separately for each mouse, except the RBC concentration
measurement error s which was simultaneously estimated across
all mice. We did not estimate any hyper parameters.
The parameter r was not directly estimated, but was derived by
solving the following equation for r using the bisection method
with tolerance 10
25
R0~l AR{
1{ 1{r ðÞ
AM
r
 !
ð23Þ
where R0 is the initial circulating reticulocyte concentration which
was also estimated. This equation was derived by considering the
total concentration of reticulocytes in bone marrow and
circulation (lAR) and subtracting from that the concentration of
reticulocytes in bone marrow. The equation is approximate
because we have not included random clearance of reticulocytes,
but this effect will be small.
The likelihood of a model with parameter vector hm given the
data for mouse m is, up to a constant of proportionality,
L hm ðÞ ! P
Nm
t~1
s{1exp {
1
2
Bmt{bmt hm ðÞ
s
   2  !
pmt hm ðÞ ðÞ
Rmt 1{pmt hm ðÞ ðÞ
Cmt{Rmt
ð24Þ
where Nm is the number of data points for mouse m, Bmt is the
coulter counter measured RBC concentration at time point t, Cmt is
the number of RBCs counted on a smear (500, 1000 or 2000), Rmt is
the number of reticulocytes counted, s is the RBC measurement
error, bmt hm ðÞ is the model solution of RBC concentration at time t,
rmt hm ðÞ is the model solution of reticulocyte concentration at time t,
and pmt hm ðÞ ~rmt hm ðÞ bmt hm ðÞ is the model solution of reticulocyte
proportion at time t. Most of the priors on the parameters were
uniformly distributed, their ranges roughly based on pre-model fitting
estimates. Based on previous estimates, the prior on the maximum
RBC lifespan AB was *N 50days,1day ðÞ [33] which helps
identifiability of reticulocyte production rate l and RBC clearance
rate k.
The Markov chain Monte Carlo jumping distributions were
multivariate normal with covariance matrices estimated from a
empirical covariance matrices calculated during an adaptive phase
[49]. The scale of the covariance matrices were tuned to give an
acceptance rate between 20 and 40% [50]. Our inferences are based
on 10
4 samples, thinned from 2610
6 iterations of a non-adaptive
Markov chain with the first half of the chain discarded as burn-in.
Model adequacy and comparison. We assess model
adequacy with standardised residual plots. By overlaying plots
for each mouse on one graph, the power of the plots to reveal poor
fit is improved. We also plot the fits to the data with 95% posterior
predictive intervals. These intervals predict where 95% of data
would lie given the model being true and the posterior distribution.
A poor fitting model would have significantly less than 95% of the
data lying within this interval. These intervals are constructed by
simulating the model using the parameter vectors from the
Markov chain and generating replicate data sets with the known
error structures and variances. At a given time point the 95%
interval is taken to lie between the 2.5 and 97.5 percentiles of the
distribution of replicated data.
To compare models we use Bayes factors [51]. We compare all
models to the model consisting of hypotheses A1, B1, C1, D1 and
E1. To calculate Bayes factors we need to calculate the marginal
likelihood of a model, P datajmodel ðÞ [52]. The Bayes factor of
model 1 and model 2 is
Bayesfactor~
P datajmodel1 ðÞ
P datajmodel2 ðÞ
ð25Þ
It is more convenient to work in decibans (tenths of a power of 10)
dB~10 log P datajmodel1 ðÞ {log P datajmodel2 ðÞ ðÞ ð 26Þ
Ad B ,5 suggests almost no difference between the models, a dB
between 5 and 10 suggest substantial evidence in favour of model 1
and a dB.10 is strong evidence in favour of model 1 [51].
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